Patients on mepolizumab, benralizumab, or dupilumab have diminished post-vaccination antibody and B cell responses to SARS-CoV-2.
Pedro Lamothe, Martin Runnstrom, Katia Faliti, Narayanaiah Cheedrala, Alberto Moreno, Mehul Suthar, Rishika Nahata, Mayuran Ravindran, Andrea Morrison-Porter, Richard Ramonell, Matthew Woodruff, Robert Swerlick, Colin Swenson, Carmen Polito, Wendy Neveu, Natalia Smirnova, Caroline Kim, Ian Hentenaar, Shuya Kyu, Zhenxing Guo, Hao Wu, Natalie Haddad, Jiwon Park, John Daiss, Suneetha Cheedarla, Andrew Neish, John Roback, Sunita Sharma, Fernando Holguin, Ignacio Sanz, Frances Eun-Hyung Lee
European Respiratory Journal Sep 2023, 62 (suppl 67) OA4215; DOI: 10.1183/13993003.congress-2023.OA4215